{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Ainos, Inc."},"Symbol":{"label":"Symbol","value":"AIMDW"},"Address":{"label":"Address","value":"8880 RIO SAN DIEGO DRIVE,SUITE 800, SAN DIEGO, California, 92108, United States"},"Phone":{"label":"Phone","value":"+1 858 869-2986"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Ainos, Inc. (NASDAQ AIMD) is a dual platform AI and biotech company pioneering SmellTech, AI diagnostics, and immune therapeutics. Ainos' proprietary AI Nose platform uses a breakthrough smell language model (SLM) to digitize scent into Smell IDs, turning invisible chemical signals into machine readable data. From robotics and smart factories to senior care and women's health, Ainos is giving AI the power to smell, unlocking a new frontier in sensory intelligence. With strategic partners, Ainos is scaling the first commercial digital olfaction platform. Ainos also develops VELDONA, a low dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. Multiple clinical programs are in motion Active clinical programs include HIV related oral warts, primary Sjogren's syndrome, and feline chronic gingivostomatitis (FCGS)."},"CompanyUrl":{"label":"Company Url","value":"https://www.ainos.com"}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}